Hiroshi Nakazato
- Molecular Biology top 2%
- Radiology, Nuclear Medicine and Imaging top 1%
- Oncology top 2%
- Cardiology and Cardiovascular Medicine top 5%
- Immunology top 5%
- Co-authors
- Shinzo OikawaMary EdmondsMaurice H. VaughanGoro KōsakiMasafumi TsujimotoChikako InuzukaShigehiko MizutaniMotomu Kuroki
- Topics
- Monoclonal and Polyclonal Antibodies Research (41 papers)Peptidase Inhibition and Analysis (23 papers)Radiopharmaceutical Chemistry and Applications (20 papers)
- Partner nations
- JapanUnited StatesBrazil
In The Last Decade
Hiroshi Nakazato
121 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Molecular Biology 2.8k
- Radiology, Nuclear Medicine and Imaging 1.1k
- Oncology 1.0k
- Cardiology and Cardiovascular Medicine 652
- Immunology 607
Countries citing papers authored by Hiroshi Nakazato
This map shows the geographic impact of Hiroshi Nakazato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Nakazato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Nakazato more than expected).
Fields of papers citing papers by Hiroshi Nakazato
This network shows the impact of papers produced by Hiroshi Nakazato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Nakazato. The network helps show where Hiroshi Nakazato may publish in the future.
Co-authorship network of co-authors of Hiroshi Nakazato
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Nakazato. A scholar is included among the top collaborators of Hiroshi Nakazato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Nakazato. Hiroshi Nakazato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 13 | |
| 3 | 33 | |
| 4 | 15 | |
| 5 | 61 | |
| 6 | 27 | |
| 7 | 155 | |
| 8 | 6 | |
| 9 | 13 | |
| 10 | 13 | |
| 11 | 86 | |
| 12 | 4 | |
| 13 | 22 | |
| 14 | 7 | |
| 15 | 84 | |
| 16 | 4 | |
| 17 | 2 | |
| 18 | 35 | |
| 19 | 17 | |
| 20 | 2 |
About Hiroshi Nakazato
Hiroshi Nakazato is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Oncology, having authored 121 papers that have together received 5.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (41 papers), Peptidase Inhibition and Analysis (23 papers) and Radiopharmaceutical Chemistry and Applications (20 papers). The work is most often cited by research in Immunology and Allergy (390 citations), Radiology, Nuclear Medicine and Imaging (1.1k citations) and Molecular Biology (2.8k citations). Hiroshi Nakazato has collaborated with scholars based in Japan, United States and Brazil. Frequent co-authors include Shinzo Oikawa, Mary Edmonds, Maurice H. Vaughan, Goro Kōsaki, Masafumi Tsujimoto, Chikako Inuzuka, Shigehiko Mizutani, Motomu Kuroki, Hisayuki Matsuo and Yasunori Tawaragi. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.